Rescue therapies of relapsed/refractory (r/r) Hodgkin’s lymphoma (HL) in the third to sixth-line provide major, yet unresolved problems. The MEPED regimen includes nuclear receptor agonists such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback